EUVIMEDEUVIMED entdecken
Crossref

Beyond inhaled antibiotics: Next-generation anti-inflammatories in bronchiectasis

Christina M. Mingora, Lauren Sullivan, Patrick A. Flume

Journal of Precision Respiratory Medicine · 01.05.2026 · 9 (1) · 11-16

DOI: 10.2500/jprm.2026.9.260003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Precision Respiratory Medicine, erschienen am 01.05.2026. Verfasst von Christina M. Mingora und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bronchiectasis is a chronic airway disease defined by permanent bronchial dilation and complicated by impaired mucociliary clearance, which can result in retention of phlegm in the airways. The model of pathophysiology encompasses a vortex of persistent infection and exaggerated neutrophil-dominant inflammation with obstruction of the airways. Available therapeutic options have targeted the obstruction and infection, but clinicians lacked an effective method of quieting the inflammation. Recent research offers a greater understanding of the inflammatory cells and their association with untoward clinical outcomes, with great interest in the neutrophil and its serine proteases.

Methods

A narrative literature review of published peer-reviewed literature from the last ten years was performed.

Results

This review describes our understanding of the pathophysiology of bronchiectasis, the clinical consequences of excess serine proteases (especially neutrophil elastase), and the evidence of recent clinical trials of novel agents that target the neutrophil.

Conclusion

The future of bronchiectasis care is expanding, beyond bronchodilators, inhaled steroids, and inhaled antibiotics, toward targeted modulation of the inflammatory cascade that drives disease progression.

Zitieren

APA

Mingora, C. M., Sullivan, L., & Flume, P. A. (2026). Beyond inhaled antibiotics: Next-generation anti-inflammatories in bronchiectasis. Journal of Precision Respiratory Medicine, 9(1), 11-16. https://doi.org/10.2500/jprm.2026.9.260003

Vancouver

Mingora CM, Sullivan L, Flume PA. Beyond inhaled antibiotics: Next-generation anti-inflammatories in bronchiectasis. Journal of Precision Respiratory Medicine. 2026;9(1):11-16. doi:10.2500/jprm.2026.9.260003

BibTeX
@article{Mingora2026,
  author = {Mingora, Christina M. and Sullivan, Lauren and Flume, Patrick A.},
  title = {Beyond inhaled antibiotics: Next-generation anti-inflammatories in bronchiectasis},
  journal = {Journal of Precision Respiratory Medicine},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {11--16},
  doi = {10.2500/jprm.2026.9.260003}
}
Kostenlos starten →